Offering Memorandum Date: April 29, 2019 THE ISSUER Name: Green Mountain Health Alliance Ltd. Head office: Address: 465 Ellis Street, Penticton, BC V2A 4M1 Phone #: 250-486-5454 E-mail address: [email protected] Fax #: 250-486-5454 Currently listed or quoted? No. These securities do not trade on any exchange or market. Reporting issuer? No SEDAR filer? No The Offering Securities offered: 450,000 in Common Shares (each, a “Share”) Price per security: $0.50 CD / $0.38 US Minimum/Maximum offering: There is no minimum. You may be the only purchaser. Funds available under the offering may not be sufficient to accomplish our proposed objectives. Minimum subscription amount: $500.00 initial investment per Subscriber of Common Shares. Payment terms: Payable directly to Green Mountain Health Alliance Ltd. Proposed closing date(s): One or more closings on dates to be determined by Green Mountain. Income tax consequences: There are important tax consequences to these securities. See item 7. Selling agent? No. See item 8. Resale restrictions You will be restricted from selling your securities for an indefinite period. See item 11. Purchaser’s rights You have 2 business days to cancel your agreement to purchase these securities. If there is a misrepresentation in this offering memorandum, you have the right to sue either for damages or to cancel the agreement. See item 12. No securities regulatory authority or regulator has assessed the merits of these securities or reviewed this offering memorandum. Any representation to the contrary is an offence. This is a risky investment. See item 9 - Risk Factors. CONTENTS FORWARD LOOKING STATEMENTS .............................................................................................................................................. 1 INCORPORATION BY REFERENCE OF CERTAIN MARKETING MATERIALS ..................................................................... 1 Item 1: Use of Available Funds ............................................................................................................................................................. 2 1.1 Funds .................................................................................................................................................................................................. 2 1.2 Use of Available Funds ................................................................................................................................................................ 2 (1) Use of Funds from This Offering ................................................................................................................................. 2 (2) Additional Capital Required .......................................................................................................................................... 3 1.3 Reallocation ..................................................................................................................................................................................... 3 1.4 Insufficient Funds .......................................................................................................................................................................... 3 Item 2: Business of Green Mountain Health Alliance Ltd. ......................................................................................................... 4 2.1 Structure ........................................................................................................................................................................................... 4 2.2 Overview ........................................................................................................................................................................................... 5 2.3 Our Vision and Values ................................................................................................................................................................. 7 2.4 Principal Products ......................................................................................................................................................................... 7 (1) Cannabis ............................................................................................................................................................................... 7 (2) Hemp ..................................................................................................................................................................................... 8 (3) Patient Care ......................................................................................................................................................................... 8 2.5 Proposed Operations ................................................................................................................................................................... 8 2.6 Properties ......................................................................................................................................................................................... 9 (1) White Lake Property ......................................................................................................................................................... 9 (2) Marron Valley Property ................................................................................................................................................ 10 (3) Kaleden Property ............................................................................................................................................................ 10 2.7 Production ..................................................................................................................................................................................... 12 2.8 The Medical Cannabis Industry ............................................................................................................................................. 12 (1) Industry Overview .......................................................................................................................................................... 13 2.9 Green House Maximum Yields .............................................................................................................................................. 14 2.10 Cannabis Oil, Extraction, and Maximizing Yield ........................................................................................................... 14 (1) Cannabis Oils ................................................................................................................................................................... 14 (2) Build Assumptions ......................................................................................................................................................... 14 (3) Medical Cannabis ........................................................................................................................................................... 16 (4) Recreational Cannabis .................................................................................................................................................. 16 (5) Customers ......................................................................................................................................................................... 17 2.11 Government Regulation ........................................................................................................................................................ 19 (1) Federal Regulatory Environment ............................................................................................................................. 19 ii (2) Provincial Regulatory Environment ......................................................................................................................... 21 (3) Municipal Regulatory Environment ......................................................................................................................... 22 2.12 Competition ............................................................................................................................................................................... 22 2.13 Marketing Plan and Strategy ............................................................................................................................................... 23 (1) Medical Cannabis General .......................................................................................................................................... 23 (2) Our Marketing Strategy ............................................................................................................................................... 24 2.14 Social Responsibility and Community Involvement ................................................................................................... 24 (1) Overview ............................................................................................................................................................................ 24 (2) Workforce .......................................................................................................................................................................... 25 (3) Community Involvement ............................................................................................................................................